Harvard Women's Health Watch

Drug cuts breast cancer risk by more than half

The aromatase inhibitor drug anastrozole (Arimidex) reduces the chance of developing breast cancer by 53% in postmenopausal women at high risk for the disease.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »